Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.
Related posts:
- MedicareCard.com – NIH Study Confirms Location of Stem Cells Near Cartilage-Rich Regions in Bones Working with mice, a team of researchers has pinpointed the location of bone generating stem cells in the spine, at the ends of shins, and in other bones. The team also has identified factors that control the stem cells’ growth. The research was conducted at the National Institutes of Health and other institutions....
- Medicare, Aiming for Near-Normal, Blood Sugar Did Not Delay Combined Risk of Diabetic Damage for People With Long-standing Diabetes, NIH-Sponsored Trial Finds In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was […]...
- NIH-Supported ACCORD Eye Study Finds Two Therapies Slow Diabetic Eye Disease Progression In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans....
- NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
- Program to Enhance Communication of Life-sustaining Treatment Preferences Associated with Closer Adherence to a Person’s Wishes when Compared with Traditional Practices, Finds NIH-Supported Study A program in which individuals used a standardized form signed by a physician to communicate their end-of-life care preferences on issues such as levels of medical intervention and tube feeding lead to significantly better adherence to treatment preferences than more traditional methods of communication, according to a new study....
- HIV/AIDS Treatment Curbs Spread of HIV Among Drug Users, According to NIH Supported Study Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, also reduced the spread of the virus among people with a history of injection drug use, according to a population-based study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published […]...
- MedicarCard.com Update – NIH Study Offers Hope to Patients with Nonalcoholic Steatohepatitis A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis (NASH), according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health...
- MedicareCard.com – Study Provides New Leads into Genetics of Cleft Lip and/or Palate A consortium of scientists supported by the National Institutes of Health reported today that it has identified two human genes that, when inherited in a slightly altered form, may play a role in causing cleft lip and/or palate (roof of the mouth), one of the world’s most common congenital malformations....
- Additional Genes Associated with Age-Related Macular Degeneration Identified Additional Genes Associated with Age-Related Macular Degeneration Identified...
- Medicare, After 40 Years, NIH-Supported Researchers Identify Possible New Treatment for Severe Vasculitis Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels. In a six-month study, a new treatment strategy provided the same benefits as the current standard of care used for more than 40 years but required less […]...
- Medicare Card, Stroke Prevention Study, Children with Sickle Cell Anemia, Iron Overload Stopped Early The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment....
- MedicareCard.com – Magnetic Stimulation Scores Modest Success as Antidepressant Some depressed patients who don’t respond to or tolerate antidepressant medications may benefit from a non-invasive treatment that stimulates the brain with a pulsing electromagnet, a study suggests. This first industry-independent, multi-site, randomized, tightly controlled trial of repetitive transcranial magnetic stimulation (rTMS) found that it produced significant antidepressant effects in a subgroup of patients, with […]...
- MedicareCard.com, National Eye Institute Shares Tips to Promote Eye Health During Healthy Vision Month 2010 During Healthy Vision Month this May, the National Eye Institute (NEI), part of the National Institutes of Health, is encouraging Americans to make vision health a priority and schedule an eye exam to help prevent unnecessary vision loss and blindness. Early detection and timely treatment can help save your sight and ensure that you’re seeing […]...
- MedicareCard.com Counts – 2010 Census: Why Is It Important? MedicareCard.com Counts - 2010 Census: Why Is It Important?...
- MedicareCard.com – U.S. Commerce Department, NIH, NSF Announce Challenge The U.S. Department of Commerce's Office of Innovation and Entrepreneurship and Economic Development Administration (EDA), today announced a new $12 million innovation competition, in partnership with the National Institutes of Health (NIH) and National Science Foundation (NSF)....